CBLI
Income statement / Annual
Last year (2020), Cytocom, Inc.'s total revenue was $262,942.00,
a decrease of 76.38% from the previous year.
In 2020, Cytocom, Inc.'s net income was -$2.40 M.
See Cytocom, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
FY-2013
|
FY-2012
|
FY-2011
|
| Period Ended |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
12/31/2013 |
12/31/2012 |
12/31/2011 |
| Operating Revenue |
$262,942.00 |
$1.11 M |
$1.14 M |
$1.95 M |
$3.52 M |
$2.71 M |
$3.70 M |
$8.49 M |
$3.57 M |
$8.79 M |
| Cost of Revenue |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Gross Profit |
$262,942.00
|
$1.11 M
|
$1.14 M
|
$1.95 M
|
$3.52 M
|
$2.71 M
|
$3.70 M
|
$8.49 M
|
$3.57 M
|
$8.79 M
|
| Gross Profit Ratio |
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
| Research and Development Expenses |
$691,070.00
|
$1.66 M
|
$3.62 M
|
$5.05 M
|
$6.50 M
|
$7.14 M
|
$9.65 M
|
$19.53 M
|
$22.50 M
|
$22.79 M
|
| General & Administrative Expenses |
$2.16 M
|
$1.82 M
|
$2.32 M
|
$2.50 M
|
$3.38 M
|
$6.36 M
|
$8.47 M
|
$12.04 M
|
$11.12 M
|
$11.11 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$2.16 M
|
$1.82 M
|
$2.32 M
|
$2.50 M
|
$3.38 M
|
$6.36 M
|
$8.47 M
|
$12.04 M
|
$11.12 M
|
$11.11 M
|
| Other Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$2.85 M
|
$3.47 M
|
$5.94 M
|
$7.55 M
|
$9.87 M
|
$13.50 M
|
$18.12 M
|
$31.56 M
|
$33.62 M
|
$33.90 M
|
| Cost And Expenses |
$2.85 M
|
$3.47 M
|
$5.94 M
|
$7.55 M
|
$9.87 M
|
$13.50 M
|
$18.12 M
|
$31.56 M
|
$33.62 M
|
$33.90 M
|
| Interest Income |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Interest Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$99,488.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Depreciation & Amortization |
$11,446.00
|
$13,782.00
|
$18,175.00
|
$21,081.00
|
$63,456.00
|
$140,135.00
|
$200,792.00
|
$471,208.00
|
$479,595.00
|
$525,513.00
|
| EBITDA |
-$2.39 M |
-$2.63 M |
-$3.59 M |
-$9.69 M |
-$2.60 M |
-$12.40 M |
$1.83 M |
-$16.79 M |
-$30.05 B |
-$3.49 M |
| EBITDA Ratio |
-9.08
|
-2.36
|
-3.16
|
-4.97
|
-0.74
|
-4.58
|
0.49
|
-1.98
|
-4.97
|
-0.4
|
| Operating Income Ratio |
-9.84
|
-2.12
|
-4.22
|
-2.87
|
-1.81
|
-3.98
|
-3.9
|
-2.72
|
-8.41
|
-2.86
|
| Total Other Income/Expenses Net |
$148,678.00
|
-$333,828.00
|
$1.09 M
|
-$4.24 M
|
$3.77 M
|
-$2.25 M
|
$14.46 M
|
$2.95 M
|
$7.63 M
|
$19.88 M
|
| Income Before Tax |
-$2.44 M
|
-$2.69 M
|
-$3.71 M
|
-$9.84 M
|
-$2.59 M
|
-$13.04 M
|
$35,366.00
|
-$20.13 M
|
-$22.41 M
|
-$5.23 M
|
| Income Before Tax Ratio |
-9.27
|
-2.42
|
-3.26
|
-5.05
|
-0.74
|
-4.82
|
0.01
|
-2.37
|
-6.28
|
-0.59
|
| Income Tax Expense |
$148,678.00
|
-$333,828.00
|
$1.09 M
|
-$4.24 M
|
$3.77 M
|
-$2.15 M
|
$14.46 M
|
$2.95 M
|
$7.63 M
|
$19.88 M
|
| Net Income |
-$2.40 M
|
-$2.65 M
|
-$3.61 M
|
-$9.71 M
|
-$2.66 M
|
-$12.64 M
|
$1.63 M
|
-$17.26 M
|
-$18.23 M
|
-$4.01 M
|
| Net Income Ratio |
-9.12
|
-2.38
|
-3.17
|
-4.98
|
-0.76
|
-4.67
|
0.44
|
-2.03
|
-5.11
|
-0.46
|
| EPS |
-0.19 |
-0.23 |
-0.32 |
-0.87 |
-0.24 |
-1.79 |
0.6 |
-7.67 |
-9.75 |
-2.47 |
| EPS Diluted |
-0.19 |
-0.23 |
-0.32 |
-0.87 |
-0.24 |
-1.79 |
0.6 |
-7.67 |
-9.75 |
-2.47 |
| Weighted Average Shares Out |
$12.40 M
|
$11.30 M
|
$11.29 M
|
$11.19 M
|
$10.99 M
|
$7.06 M
|
$2.70 M
|
$2.25 M
|
$1.87 M
|
$1.63 M
|
| Weighted Average Shares Out Diluted |
$12.40 M
|
$11.30 M
|
$11.29 M
|
$11.19 M
|
$10.99 M
|
$7.06 M
|
$2.70 M
|
$2.25 M
|
$1.87 M
|
$1.63 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
